Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis

References

• Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138: 19–20
   Google Scholar
• Grayston J. T., Campbell L. A., Kuo C. C., Mordhorst C. H., Saikku P., Thom D. H., et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161: 618–25
   PubMed Web of Science ®Google Scholar
• Thom D. H., Grayston J. T., Siscovick D. S., Wang S. P., Weiss N. S., Daling J. R. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary disease. JAMA 1992; 268: 68–72
   PubMed Web of Science ®Google Scholar
• Linnanmaki E., Leinonen M., Mattila K., Nieminen M. S., Valtonen V., Saikku P. Chlamydia pneumoniae – specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130–4
   PubMed Web of Science ®Google Scholar
• Hoffmeister A., Rothenbacher D., Wanner P., Bode G., Persson K., Brenner H., et al. Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease. J Am Coll Cardiol 2000; 35: 112–18
   Google Scholar
• Ridker P. M., Kundsin R. B., Stampfer M. J., Poulin S., Hennekens C. H. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999; 9: 1161–4
   Google Scholar
• Haider A. W., Wilson P. W. F., Larson M. G., Evans J. C., Michelson E. L., Wolf P. A., et al. The Association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol 2002; 40: 1408–13
   PubMed Web of Science ®Google Scholar
• Young J. L., Libby P., Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 2002; 88: 554–67
   PubMed Web of Science ®Google Scholar
• Kohara K., Tabara Y., Yamamoto Y., Igase M., Miki T. Chlamydia pneumoniae seropositivity is associated with increased plasma levels of soluble cellular adhesion molecules in community‐dwelling subjects: the Shimanami Health Promoting Program (J‐SHIPP) study. Stroke 2002; 33: 1474–9
   Google Scholar
• Kaukoranta‐Tolvanen S. S. E., Teppo A. M., Laitinen K., Saikku P., Linnavuori K., Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 1996; 21: 215–21
   PubMed Web of Science ®Google Scholar
• Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C‐reactive protein, albumin, or leukocyte count with coronary heart disease – meta‐analyses of prospective studies. JAMA 1998; 279: 1477–82
   PubMed Web of Science ®Google Scholar
• Leinonen M., Saikku P. Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis. Am Heart J 1999; 138: 504–6
   Google Scholar
• Laurila A., Bloigu A., Nayha S., Hassi J., Leinonen M., Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 2910–13
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Cushman M., Stampfer M. J., Tracy R. P., Hennekens C. H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973–9
   PubMed Web of Science ®Google Scholar
• Oberman A., Jones W. B., Riley C. P., Reeves T. J., Sheffield L. T., Turner M. E. Natural history of coronary artery disease. Bull NY Acad Med 1972; 48: 1109–25
   PubMedGoogle Scholar
• Gensini G. G., Kelly A. E. Reassessment of contrast agent for coronary angiography. Curr Ther Res Clin Exp 1976; 19: 631–6
   Google Scholar
• Kiechl S., Egger G., Mayr M., Wiedermann C. J., Bonora E., Oberhollenzer F., et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001; 103: 1064–70
   PubMed Web of Science ®Google Scholar
• Rattazzi M., Puato M., Faggin E., Bertipaglia B., Zambon A., Pauletto P. C‐reactive protein and interleukin‐6 in vascular disease: culprits or passive bystanders?. J Hypertens 2003; 21: 1787–803
   PubMed Web of Science ®Google Scholar
• Thom D. H., Wang S. P., Grayston J. T., Siscovick D. S., Stewart D. K., Kronmal R. A., et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991; 11: 547–51
   PubMed Web of Science ®Google Scholar
• Jaremo A., Richter A. Chlamydia pneumoniae IgG and the severity of coronary atherosclerosis. Eur J Intern Med 2004; 15: 508–10
   Google Scholar
• Romano S., Penco M., Fratini S., Di Pietro M., Sessa R., Del Piano M., et al. Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability. Int J Cardiol 2004; 95: 95–9
   Google Scholar
• Nishimura M., Hashimoto T., Kobayashi H., Fukuda T., Okino K., Yamamoto N., et al. Close association of Chlamydia pneumoniae IgA seropositivity by ELISA with the presence of coronary artery stenosis in haemodialysis patients. Nephrol Dial Transplant 2005; 20: 1944–50
   Google Scholar
• Halme S., von Hertzen L., Bloigu A., Kaprio J., Koskenvuo M., Leinonen M., et al. Chlamydia pneumoniae‐specific cell‐mediated and humoral immunity in healthy people. Scand J Immunol 1998; 47: 517–20
   Google Scholar
• Schumacher A., Seljeflot I., Lerkerod A. B., Sommervoll L., Otterstad J. E., Arnesen H. Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease. Eur J Clin Invest 2005; 35: 431–7
   Google Scholar
• Paltiel O., Kark J. D., Leinonen M., Saikku P. High prevalence of antibodies to Chlamydia pneumoniae: determinants of IgG and IgA seropositivity among Jerusalem residents. Epidemiol Infect 1995; 114: 465–73
   PubMed Web of Science ®Google Scholar
• Ferrari M., Poli A., Olivieri M., Tardivo S., Biasin C., Balestreri F., et al. Seroprevalence of Chlamydia pneumoniae antibodies in a young adult population sample living in Verona. European Community Respiratory Health Survey (ECRHS) Verona. Infection 2000; 28: 38–41
   Google Scholar
• Gordon D. J., Probstfield J. L., Garrison R. J., Neaton J. D., Castelli W. P., Knoke J. D., et al. High‐density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989; 79: 8–15
   PubMed Web of Science ®Google Scholar
• Laurila A., Bloigu A., Nayha S., Hassi J., Leinonen M., Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 2910–13
   PubMed Web of Science ®Google Scholar
• Turkoglu C., Sonmez E., Aydinli A. Relationship between dyslipidemia, C‐reactive protein and serological evidence of Chlamydia pneumoniae in Turkish patients with coronary artery diseases. New Microbiol 2004; 27: 229–34
   Google Scholar
• Beisal W. R. Metabolic response to infection. Ann Rev Med 1975; 26: 9–20
   Google Scholar
• Koh W. P., Taylor M. B., Hughes K., Chew S. K., Fong C. W., Phoon M. C., et al. Seroprevalence of IgG against Chlamydia pneumoniae in Chinese Malays and Asian Indians in Singapore. Int J Epidemiol 2002; 31: 1001–7
   Google Scholar
• Netea M. G., Selzman C. H., Kullberg B. J., Galama J. M., Weinberg A., Stalenhoef A. F., et al. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 2000; 30: 541–9
   PubMed Web of Science ®Google Scholar
• Haddy N., Sass C., Droesch S., Zaiou M., Siest G., Ponthieux A., et al. IL‐6, TNF‐alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 2003; 170: 277–83
   PubMed Web of Science ®Google Scholar
• Schumacher A., Seljeflot I., Lerkerod A. B., Sommervoll L., Otterstad J. E., Arnesen H. Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease. Atherosclerosis 2002; 164: 153–60
   Web of Science ®Google Scholar
• Mendall M. A., Patel P., Ballam L., Strachan D., Northfield T. C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J 1996; 312: 1061–5
   PubMed Web of Science ®Google Scholar
• Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., et al. Role of IL‐6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315–25
   PubMed Web of Science ®Google Scholar
• Schumacher A., Seljeflot I., Lerkerod A. B., Sommervoll L., Otterstad J. E., Arnesen H. Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans?. Clin Microbiol Infect 2002; 8: 654–61
   PubMedGoogle Scholar
• Hu H., Pierce G. N., Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999; 103: 747–53
   PubMedGoogle Scholar